Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Covance Inc.    

COVANCE INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsAnalysisCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Latest news on COVANCE INC.
2016Abbott Laboratories Acquisition
DJ
2015COVANCE : LabCorp Completes Acquisition of Covance
PU
2015COVANCE : Launches New Solution to Bridge Preclinical to Clinical Development
PR
2014COVANCE : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
BU
2014COVANCE : Life Sciences Tools and Services Equities Coverage - Agilent Technolog..
PR
2014COVANCE : Morgan & Morgan : Announces That It is Investigating the Sale of Covan..
PR
2014COVANCE : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Cov..
BU
2014COVANCE : SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Pro..
BU
2014COVANCE : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Co..
PR
2014COVANCE : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Cov..
BU
2014COVANCE : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of B..
BU
2014COVANCE : Stockholders Encouraged to Contact Securities Law Firm about Takeover
PR
2014COVANCE : SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger M..
PR
2014COVANCE : Ryan & Maniskas, LLP : Announces Investigation of Covance Inc.
PR
2014COVANCE : Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of A..
PR
2014COVANCE : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Cov..
PR
2014COVANCE : Harwood Feffer LLP : Announces Investigation of Covance Inc.
PR
2014Dow, S&P 500 close slightly lower; semis boost Nasdaq
RE
2014COVANCE : SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Pro..
BU
2014LabCorp to pay $6.1 billion for drug trial company Covance
RE
2014LabCorp to pay $6.1 billion for drug trial company Covance
RE
2014COVANCE : EQUITY ALERT: The Rosen Law Firm Announces Investigation of Covance In..
BU
2014COVANCE : CVD INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of th..
BU
2014COVANCE : SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylo..
BU
2014COVANCE : CVD) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash f..
BU
2014COVANCE : Shareholder Alert - Buyout of Covance Inc. - National Securities Law F..
PR
2014COVANCE : LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating Wo..
BU
2014COVANCE INC. : quaterly earnings release
2014COVANCE : Technical Coverage on Life Sciences Tools and Services Equities - Agil..
PR
2014COVANCE : Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadershi..
PR
2014COVANCE : Invites You to Join the Webcast of Its Third Quarter 2014 Financial Re..
PR
2014COVANCE : and Frenova Renal Research Establish
PU
2014COVANCE : To Present At The Morgan Stanley Global Healthcare Conference
PR
2014COVANCE : Financial Results, Investor Meeting Schedule, Dividend Declaration, an..
PR
2014COVANCE : Invites You to Join the Webcast of Its Second Quarter 2014 Financial R..
PR
2014COVANCE : Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro..
PR
2014COVANCE : Increases its Medical and Scientific Leadership with Two Senior-Level ..
PU
2014COVANCE : C O R R E C T I O N -- Covance Inc./
PU
2014COVANCE : New Laws, Pricing of Offering, Recognitions, Donations, and Upcoming C..
PR
2014COVANCE : C O R R E C T I O N -- Covance Inc./
PR
2014COVANCE : MarketPlace, a New Solution to Expedite Biopharmaceutical Development
PU
2014COVANCE : To Present At The William Blair 34th Annual Growth Stock Conference
PR
2014COVANCE : To Present At The Goldman Sachs 35th Annual Global Healthcare Conferen..
PR
2014COVANCE : To Present At The Jefferies 2014 Global Healthcare Conference
PR
2014COVANCE : Acquires Medaxial
PR
2014COVANCE : to Present at the UBS Global Healthcare Conference
PR
2014COVANCE : To Present At The Bank Of America Merrill Lynch Health Care Conference
PR
2014COVANCE : to Present at The Baird 2014 Growth Stock Conference
PR
2014COVANCE : Launches New Brand: Solutions Made Real™
PU
2014COVANCE : Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro ..
PR
2014COVANCE : Launches New Brand: Solutions Made Real(TM)
PR
2014COVANCE : and Lilly Honored with Alliance Excellence Award
PR
2014COVANCE : Invites You to Join the Webcast of Its First Quarter 2014 Financial Re..
PR
2014COVANCE : expands Global Biologics Capabilities
PU
2014COVANCE INC. : Covance To Present At The Raymond James 35th Annual Institutional..
PR
2014COVANCE INC. : Covance To Present At The Citi 2014 Global Healthcare Conference
PR
2014COVANCE INC. : Covance to Present at the Leerink Swann 2014 Global Healthcare Co..
PR
2014COVANCE INC. : Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro F..
PR
2014COVANCE INC. : Covance To Open Nutritional Chemistry And Food Safety Site In Har..
PU
2014COVANCE INC. : Covance Appoints Dr. Barry J. Goldstein to Lead Expanded Cardiova..
PU
2014COVANCE INC. : Covance to Present at the 32nd Annual J. P. Morgan Healthcare Con..
PR
2014COVANCE INC. : Invites You to Join the Webcast of Its Fourth Quarter 2013 Financ..
PR
2013COVANCE INC. : Covance Board Authorizes $100 Million Stock Buyback
PR
2013COVANCE INC. : Court Orders, Stock Price Movements, FDA Approvals and Strategic ..
PR
2013COVANCE INC. : Covance Central Laboratories and NeoGenomics Enter into Exclusive..
PR
2013CAXTON ASSOCIATES LP 3Q 13F : Largest Eliminations
DJ
2013CAXTON ASSOCIATES LP 3Q 13F : Holdings As Of Sep 30 -2-
DJ
2013CAXTON ASSOCIATES LP 3Q 13F : Holdings As Of Sep 30
DJ
2013COVANCE INC. : Covance To Present At The Credit Suisse Healthcare Conference
PR
2013COVANCE INC. : Covance and Pathoquest Establish Exclusive Collaboration to Provi..
PU
2013COVANCE INC. : Covance Reports Third Quarter Net Revenue Of $607 Million, Pro Fo..
PR
2013COVANCE INC. : quaterly earnings release
2013COVANCE INC. : Extended Partnership, Quarterly Reports, and Note Purchase Agreem..
PR
2013COVANCE INC. : Covance Announces $250 Million Long-Term Private Placement Debt F..
PR
2013COVANCE INC. : Covance Launches External Laboratory Management Services for Spec..
PU
1  2  3  4Next
Chart COVANCE INC.
Duration : Period :
Covance Inc. Technical Analysis Chart | US2228161004 | 4-Traders
Managers
NameTitle
John D. Ratliff Chief Executive Officer
F. Samuel Eberts President, Secretary & Director
John Gransee Chief Financial Officer
Glenn A. Eisenberg Director
Brian H. Nutt Principal
Sector and Competitors
1st jan.Capitalization (M$)
COVANCE INC.0
CELLTRION, INC.--.--%31 274
IQVIA HOLDINGS INC0.17%20 671
LONZA GROUP-6.84%18 497
NEKTAR THERAPEUTICS50.95%14 892
INCYTE CORPORATION-26.02%14 841